Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1996 Jul;42(1):11–14. doi: 10.1046/j.1365-2125.1996.03663.x

The asthma death problem revisited

R W FULLER 1
PMCID: PMC2042637  PMID: 8807138

Abstract

1Asthma is a potentially dangerous disease. Asthma deaths occur at varying degrees throughout the world and there is evidence for epidemics occurring in different populations at different times. Such epidemics have been noted as early as last century. Much investigation has been made into the role of inhaled β-adrenoceptor agonists in these epidemics and indeed there is some evidence fenoterol is implicated. However, evidence for other β-adrenoceptor agonists is not substantiated.

2It is also noted that asthma deaths are not all the same, there being at least two types: deaths occurring in chronic severe asthmatics related to disease severity and sudden deaths of an anaphylactic nature that can occur in asthmatics of any disease severity.

3The important next step in the study of asthma deaths is to concentrate on other important factors rather than the role of therapy which cannot explain all the epidemics and the background instance of asthma death.

Keywords: asthma death, β-adrenoceptor agonists, CFCs, epidemiology

Full Text

The Full Text of this article is available as a PDF (159.8 KB).


Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES